Novel Derivatives of Benfluron and Dimefluron Synthesis and Anticancer activity

Author(s): Lenka Sucha, Marek Kolenic, Jiri Kratochvil, Milan Pour, Milan Nobilis, Eva Cermakova, Martina Rezacova, Pavel Tomsik

Journal Name: Letters in Drug Design & Discovery

Volume 12 , Issue 10 , 2015

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


In this study, we tried to improve the anticancer properties of two potential cytostatic agents based on benzo[c]fluorene, benfluron and dimefluron, by the synthesis of their C-7 derivatives. In the new derivatives, we observed the effect in Ehrlich tumour-bearing mice as well as in human MCF-7, BT-549 and MDA-MB-231 cells. All of the compounds tested showed a strong inhibitory effect in vitro. When tested in vivo, their systemic toxicity in vivo was promisingly low. Benfluron and its O-methyloxime as well as dimefluron and its oxime, thiosemicarbazone and hydrazone inhibited tumour growth in vivo. Only benfluron and hydrazone of dimefluron prolonged the survival. Proliferating cell nuclear antigen (PCNA) protein was decreased in tumours treated with benfluron and O-methyloxime of dimefluron in cancer tissue. Benfluron thiosemicarbazone increased the infiltration of tumour with T-lymphocytes. Taken together, all derivatives were more cytotoxic then their parent compounds, but not necessarily more effective in vivo.

Keywords: Anticancer effects, benzo[c]fluorene derivatives, cytotoxicity, MCF-7, solid Ehrlich tumour, synthesis.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 12 October, 2015
Page: [787 - 801]
Pages: 15
DOI: 10.2174/1570180812666150529204508
Price: $65

Article Metrics

PDF: 19